CIK 0001676725 · Large accelerated filer
IDEAYA Biosciences, Inc.
Sign in to watch- Ticker
- IDYA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474268251
- Phone
- 650-443-6209
- Business address
- 5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $985,397
- in 1 filing, $985K under 10b5-1 plans
Net −$985,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-07-26 | Stone Paul A. SVP, General Counsel | Option exercise · Stock Option (right to buy) | −10,000 | 145,932 | ||
| 2019-07-10 | Hager Jeffrey SVP, Chief Technology Officer | Option exercise | +7,145 | $4.31 | $31K | 122,656 |
| 2019-07-10 | Hager Jeffrey SVP, Chief Technology Officer | Option exercise · Stock Option (right to buy) | −7,145 | 33,275 | ||
| 2019-06-19 | Hager Jeffrey SVP, Chief Technology Officer | Option exercise | +8,628 | $4.31 | $37K | 115,511 |
| 2019-06-19 | Hager Jeffrey SVP, Chief Technology Officer | Option exercise · Stock Option (right to buy) | −8,628 | 40,420 | ||
| 2019-05-28 | Alexandria Venture Investments, LLC 10% owner | Conversion | +382,384 | 382,384 | ||
| 2019-05-28 | Alexandria Venture Investments, LLC 10% owner | Purchase | +50,000 | $10.00 | $500K | 432,384 |
| 2019-05-28 | Alexandria Venture Investments, LLC 10% owner | Conversion · Series A preferred stock | −3,149,405 | 0 | ||
| 2019-05-28 | Alexandria Venture Investments, LLC 10% owner | Conversion · Series B preferred stock | −772,499 | 0 | ||
| 2019-05-28 | DIEKMAN JOHN D Director | Conversion | +1,721,898 | 2,026,098 | ||
| 2019-05-28 | DIEKMAN JOHN D Director | Conversion | +578,447 | 2,604,545 | ||
| 2019-05-28 | DIEKMAN JOHN D Director | Conversion | +71,745 | 84,420 | ||
| 2019-05-28 | DIEKMAN JOHN D Director | Conversion | +24,101 | 108,521 | ||
| 2019-05-28 | DIEKMAN JOHN D Director | Purchase | +240,000 | $10.00 | $2.4M | 2,844,545 |
| 2019-05-28 | DIEKMAN JOHN D Director | Purchase | +10,000 | $10.00 | $100K | 118,521 |
| 2019-05-28 | DIEKMAN JOHN D Director | Conversion · Series A Preferred Stock | −1,721,898 | 0 | ||
| 2019-05-28 | DIEKMAN JOHN D Director | Conversion · Series B Preferred Stock | −578,447 | 0 | ||
| 2019-05-28 | DIEKMAN JOHN D Director | Conversion · Series A Preferred Stock | −71,745 | 0 | ||
| 2019-05-28 | DIEKMAN JOHN D Director | Conversion · Series B Preferred Stock | −24,101 | 0 | ||
| 2019-05-28 | Stone Paul A. SVP, General Counsel | Conversion | +1,721,898 | 2,026,098 |
Page 17 of 19 · 370 trades